Search Results 1621-1630 of 17970 for Lupus
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Participants that report lower back pain and meet criteria for being on the study will be randomized to receive one of the two types of massage, EMMA or a ...
The Lymphoma Biostatistics and Data Science Laboratory led by Matthew J. Maurer, Sc.D., M.S., develops and validates statistical models to help assess risk ...
This study will test a study drug called cemiplimab to see if it can help treat early-stage cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.
This phase Ib/II clinical trial studies the side effects and best dose of venetoclax and how well it works when given together with vincristine liposomal in ...
This tool could alert a patient's primary care team of a probable IPF diagnosis based on comorbidities and risk scores. The tool should prompt earlier referral ...
Experts in biomedical engineering, neurosurgery, neurology, orthopedics and more guide research in Mayo Clinic's Department of Neurologic Surgery.
Martin-Castillo B, Verdura S, Llop-Hernandez A, Lupu R, Cuyas E, Menendez JA. Metabolic hallmarks of trastuzumab resistance. Expert Opin Ther Targets.
Mayo Clinic researcher Louis J. Faust, Ph.D., leverages wearable health sensors to enhance healthcare delivery models and improve patient outcomes.
Progress in the diagnosis and treatment of this kidney cancer have greatly improved the outlook for children with the condition.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.